Apriem Advisors’s ProShares Ultra Health Care RXL Stock Holding History

Apriem Advisors’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-216	Closed	-$3K	–	639
2016 Q2	$3K	Buy	+216	New	+$3.34K	﹤0.01%	517

Other funds holding RXL

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Apriem Advisors's RXL Position: Q3 2016 in Review

Apriem Advisors sold out of ProShares Ultra Health Care (RXL) in Q3 2016, closing a stake of 216 shares — an estimated $3K sold.

Apriem Advisors first reported a position in RXL in Q2 2016 and held it in 1 quarter. The position peaked at $3K in Q2 2016. 17 funds tracked by Wall St. Rank hold RXL as of Q3 2016.

Apriem Advisors reported no remaining ProShares Ultra Health Care position as of Q3 2016 after selling out during the quarter.
Apriem Advisors sold 216 ProShares Ultra Health Care shares in Q3 2016, an estimated $3K.
Apriem Advisors first reported a position in ProShares Ultra Health Care in Q2 2016 and held it in 1 quarter.
Apriem Advisors's ProShares Ultra Health Care position peaked at $3K in Q2 2016.
17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q3 2016.

Based on Apriem Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.